BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2025 9:23:12 AM | Browse: 417 | Download: 858
Publication Name World Journal of Clinical Oncology
Manuscript ID 107438
Country China
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Minireviews
Article Title Current status and advances in the treatment of colorectal cancer with liver metastases
Manuscript Source Invited Manuscript
All Author List Wei-Xing Liu, Chuang Jiang and Jia-Xin Li
ORCID
Author(s) ORCID Number
Jia-Xin Li http://orcid.org/0009-0005-8538-5900
Funding Agency and Grant Number
Funding Agency Grant Number
Project of Guizhou Provincial Department of Science and Technology No. Qian Ke He Cheng Guo-LC[2024]109
Corresponding Author Jia-Xin Li, Assistant Professor, MD, Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu 610041, Sichuan Province, China. lijiaxin@scu.edu.cn
Key Words Colorectal cancer; Liver metastases; Treatment strategies; Cancer; Review
Core Tip Colorectal cancer liver metastases (CRLM) present a significant clinical challenge, yet surgical resection of both primary and metastatic lesions can yield favorable outcomes. Advances in systemic therapies enable conversion therapy for initially unresectable cases, offering potential surgical opportunities. However, key controversies persist, including optimal timing of systemic therapy, the role of neoadjuvant treatment, and the choice between simultaneous or staged surgeries. This review outlines current CRLM management strategies and highlights unresolved issues to guide clinical decision-making.
Publish Date 2025-07-22 09:23
Citation

Liu WX, Jiang C, Li JX. Current status and advances in the treatment of colorectal cancer with liver metastases. World J Clin Oncol 2025; 16(7): 107438

URL https://www.wjgnet.com/2218-4333/full/v16/i7/107438.htm
DOI https://dx.doi.org/10.5306/wjco.v16.i7.107438
Full Article (PDF) WJCO-16-107438-with-cover.pdf